| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Valproic Acid | FAERS: 23 | US FAERS | |
| 2 | Teriparatide | FAERS: 8 | US FAERS | |
| 3 | alvimopan | FAERS: 3 | US FAERS | |
| 4 | Risperidone | FAERS: 2 | US FAERS | |
| 5 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 6 | Cyclophosphamide | FAERS: 1 | US FAERS | |
| 7 | Cyclosporine | FAERS: 1 | US FAERS | |
| 8 | Epoprostenol | FAERS: 1 | US FAERS | |
| 9 | Insulin degludec | FAERS: 1 | US FAERS | |
| 10 | Ranitidine | FAERS: 1 | US FAERS | |
| 11 | Telbivudine | FAERS: 1 | US FAERS | |
| 12 | Telmisartan | FAERS: 1 | US FAERS | |
| 13 | Thyroxine | FAERS: 1 | US FAERS | |
| 14 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 15 | Triumeq | FAERS: 1 | US FAERS | |
| 16 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 17 | regorafenib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.